![]() |
Volumn 2, Issue 5, 2004, Pages 360-361
|
Dengue
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CAPSID PROTEIN;
DENGUE VACCINE;
DRINKING WATER;
GAMMA INTERFERON;
IMMUNOGLOBULIN M;
INSECTICIDE;
INTERLEUKIN 2;
LARVICIDAL AGENT;
LIVE VACCINE;
TUMOR NECROSIS FACTOR ALPHA;
VIRUS ENVELOPE PROTEIN;
VIRUS ENZYME;
VIRUS PROTEIN;
VIRUS VACCINE;
AEDES AEGYPTI;
ANTIBODY DEPENDENT ENHANCEMENT;
ANTIBODY DETECTION;
ARTICLE;
CLINICAL TRIAL;
CYTOLYSIS;
DENGUE;
DENGUE VIRUS;
DRUG COST;
DRUG SAFETY;
DRUG TARGETING;
FLAVIVIRUS;
GENOTYPE;
HEALTH PROGRAM;
HUMAN;
INSECT BITE;
INSECT CONTROL;
MEDICAL INFORMATION SYSTEM;
PATHOGENESIS;
PATHOPHYSIOLOGY;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
STRAIN DIFFERENCE;
T LYMPHOCYTE;
UNITED STATES;
VIRUS CAPSID;
VIRUS LOAD;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ANIMAL;
DISEASE CARRIER;
IMMUNOLOGY;
REVIEW;
VIROLOGY;
AEDES AEGYPTI;
DENGUE VIRUS;
FLAVIVIRUS;
INSECTA;
ANIMALS;
DENGUE;
DENGUE VIRUS;
HUMANS;
INSECT VECTORS;
VIRAL VACCINES;
|
EID: 2442531946
PISSN: 17401526
EISSN: None
Source Type: Journal
DOI: 10.1038/nrmicro890 Document Type: Article |
Times cited : (39)
|
References (15)
|